Overview

Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This study is designed to find out whether taking antipsychotic medication once every two weeks by injection compared to taking daily oral medication will help people with schizophrenia maintain better control of their symptoms.
Phase:
Phase 4
Details
Lead Sponsor:
Northwell Health
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Antipsychotic Agents
Aripiprazole
Olanzapine
Paliperidone Palmitate
Quetiapine Fumarate
Risperidone
Ziprasidone